10:I[8479,["349","static/chunks/349-c9bb88602114b6df.js","173","static/chunks/173-8ffc04d433c3339f.js","865","static/chunks/865-f26eeb7d8a4ff1d6.js","444","static/chunks/app/episode/%5Buuid%5D/page-e9df19c6dc9fc3dd.js"],"EpisodeClient"] 11:T4f6,A federal bankruptcy judge says he'll rule Wednesday in the case of Purdue Pharma, makers of OxyContin. The company is owned by the Sackler family, who are at the center of a national reckoning over the deadly opioid epidemic.

NPR addiction correspondent Brian Mann has been covering the story of Purdue Pharma for years, and explains how the Sacklers may emerge from Purdue's bankruptcy proceedings with their personal fortunes in tact. Find more of Brian's reporting here or follow him on Twitter @BrianMannADK.

In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.

Email us at considerthis@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy12:T4f6,A federal bankruptcy judge says he'll rule Wednesday in the case of Purdue Pharma, makers of OxyContin. The company is owned by the Sackler family, who are at the center of a national reckoning over the deadly opioid epidemic.

NPR addiction correspondent Brian Mann has been covering the story of Purdue Pharma for years, and explains how the Sacklers may emerge from Purdue's bankruptcy proceedings with their personal fortunes in tact. Find more of Bri

How A Bankruptcy Deal Could Offer Clean Slate For Opioid Billionaires